“Capmatinib in patients with MET-positive advanced non-small cell lung cancer: analysis of the Russian cohort in the Geometry mono-1 study” (2022) Voprosy onkologii, 68(6), pp. 758–767. doi:10.37469/0507-3758-2022-68-6-758-767.